Sunshine Biopharma (SBFM) Times Interest Earned: 2012-2024
Historic Times Interest Earned for Sunshine Biopharma (SBFM) over the last 11 years, with Dec 2024 value amounting to -$238.92.
- Sunshine Biopharma's Times Interest Earned fell 505.93% to -$238.92 in Q4 2024 from the same period last year, while for Dec 2024 it was -$65.44, marking a year-over-year decrease of 53.81%. This contributed to the annual value of -$662.43 for FY2024, which is 1800.74% down from last year.
- Latest data reveals that Sunshine Biopharma reported Times Interest Earned of -$238.92 as of Q4 2024, which was up 95.38% from -$5,177 recorded in Q2 2024.
- In the past 5 years, Sunshine Biopharma's Times Interest Earned registered a high of -$1.99 during Q2 2021, and its lowest value of -$858,990 during Q3 2022.
- For the 3-year period, Sunshine Biopharma's Times Interest Earned averaged around -$86,582, with its median value being -$167.01 (2024).
- As far as peak fluctuations go, Sunshine Biopharma's Times Interest Earned crashed by 8,109,137.82% in 2022, and later skyrocketed by 100.00% in 2023.
- Sunshine Biopharma's Times Interest Earned (Quarterly) stood at -$3.26 in 2020, then crashed by 134.44% to -$7.63 in 2021, then slumped by 11,429.02% to -$880.12 in 2022, then skyrocketed by 95.52% to -$39.43 in 2023, then tumbled by 505.93% to -$238.92 in 2024.
- Its last three reported values are -$238.92 in Q4 2024, -$5,177 for Q2 2024, and -$27.46 during Q1 2024.